
Developer of Cardiac Disease Treatment Devices
Berlin HealsAnnouncement in the journal "SC Heart Failure journal》Release onMicrocurrent Technology---C-MIC Two-year clinical data of FIM.Research shows:Research results showing clinical benefits maintained even after active treatment termination.
Specific Research Data
No device-related adverse events reported within two years.
6-Minute Walk Distance Increased by Over 200 Meters at 6 Months, Remaining 191 Meters Above Baseline After Two Years
New York Heart Association Functional Classification and SF-36 Quality of Life Score Continuously Improve
Among 7 patients, only 1 patient required a restartC-MICTreatment
PI Evaluation
"These findings provide important clinical evidence for the long-term potential of C-MIC therapy. Most excitingly, cardiac function and patient quality of life continued to improve even after device discontinuation, indicating the therapy's ability to alter disease progression."
---Dragana Kosevic Co-Chief Investigator
Executive Evaluation
"The publication of this study strengthens our confidence in the transformative potential of microcurrent therapy for heart failure treatment. The two-year results validate the safety and sustained efficacy of C-MIC, laying the groundwork for larger-scale clinical trials."
---John Brumfield CEO of Berlin Heals
Even ifPause, Still Able to Continuously Improve